30. Lococo F, Ye BH, Listra F. Rearrangements of the BCL-6 gene in diffuse large-cell non-Hodgkin lymphoma. Blood 1994;83:1757-9.
31. Kanavaros P, Gaulard P, Charlotte F. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B lymphomas. Am J Pathol 1995;146:735-41.
32. DiGiuseppe JA, Nelson WG, Seifter EJ. Intravascular lymphomatosis: A clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 1994;12:2573-9.
33. Tilly H, Gaulard P, Lepage E. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype and outcome. Blood 1997;90:3725-34.
34. Sol G del, Lemant L, Mariamé B. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 1997;89:1483-90.
35. Al-Hashmi I, Decoteau J, Gruss HJ, Zlenska M, Thorner F, Fcon A, et al. Establishment of a cytokine producing anaplastic large-cell lymphoma cell line containing the t (2;5) translocation potential role of cytokines in clinical manifestations. Leuk Lymphoma 2001;40(5-6):599-611.
36. Baskin GB, Cremer KJ, Levy LS. Comparative pathobiology of HIV-and siv-associated lymphoma. AIDS Res Hum Retroviruses 2001;17(8):745-51.
37. Tsujimoto T, Cossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human folicular lymphoma. Science 1985;288:1440-3.
38. Arcinas M, Heckman CA, Mehew JW, Borer LM. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in folicular and transformed lymphoma. Cancer Res 2001;61(13):5202-6.
39. Guinan EC, Gribben JG, Boussiotis VA. Pivotal role of the B7:CD28 pathway: transplantation tolerance and tumor immunity. Blood 1994;84:3261-82.
40. Chott A, Kaserer K, Augustin I. Ki-1 positive large cell lymphoma; A clinicopathologic study of 41 cases. Am Surg Pathol 1990;14:432-48.
41. Pulford K, Lamant L, Morris SW. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM-ALK) proteins in normal and neoplastic cells with the monoclonal antibody ALK-1. Blood 1997;89:1394-1404.
42. Melnyk A, Rodríguez A, Pugh WC. Evaluation of the revised European- American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggresive non-Hodgkin lymphoma. Blood 1997;89:4514-20.
43. ENCICLOPEDIA R. LINFOMA [monografía en Internet]. WIKIPEDIA: CIENCIAS MEDICAS; 2009 [citado 1 Junio 2009]. Disponible en: http://http://es.wikipedia.org/wiki/Linfoma
44. CAPITULO 158 LINFOMAS MSD SECCIÓN [monografía en Internet]. MSD SECCIÓN 14. TRASTORNOS DE LÑA SANGRE: CIENCIAS MEDICAS; 2005 [citado 1 Enero 2009]. Disponible en: http://http://www.msd.es/ publicaciones/ mmerck_hogar/seccion_ 14/ seccion_ 14_158.html
45. David N.Liebowitz, MD, Stephanie F.Williams,MD. Lymphomas. Seminars in Oncology 1998; 25: No4.
46. Dirk Hasenclever, Ph.D., Volker Diehl, M.D. A prognostic score for advanced hodgkin´s disease. NEJM 1998;339:1506-1514.
47. James O.Armitage, M.D.. Treatment of Non-Hodgkin´s Lymphoma. NEJM 1993;328:1023-1029.Up to Date Versión 9.1, 2001.
48. Cecil – Textbook of Medicine. W.B. Saunders. 21st edition. 2000;179:962-926.
49. Guillermo Bustos P. Pautas y procedimientos en Medicina Interna. Linfomas [monografía en Internet]. REVISTA ELECTRÓNICA DE PORTALESMEDICOS: C-M; 2008 [citado 1 Enero 2009]. Disponible en: http://www.portalesmedicos.com/ publicaciones/ articles/ 921/1/ Pautas-y-procedimientos-en-Medicina-Interna-Linfomas.html